Table III.
Group II (NAFL) | |||||
---|---|---|---|---|---|
Bee venom treated | |||||
Parameter | Group I (control) (n=10) | Untreated (n=10) | 0.01 mg/kg (n=10) | 0.05 mg/kg (n=10) | 0.1 mg/kg (n=10) |
Serum tGSH (µmol/l) | 83.61±5.34 | 64.84±8.71a | 65.09±10.57a | 69.65±16.09a | 69.37±7.37a |
Serum GSH (µmol/l) | 73.95±4.84 | 43.58±10.85a | 49.91±8.89a | 54.74±17.64a | 56.30±9.72a |
Serum GSSG (µmol/l) | 4.82±1.08 | 10.63±1.50a | 7.59±2.11a,b | 7.47±1.27a,b | 6.55±1.87b |
Serum GSH/GSSG | 15.93±3.19 | 4.29±1.67a | 7.04±2.17a | 7.72±3.10a | 9.55±4.07a,b |
Hepatic tGSH (µmol/g liver) | 1.92±0.20 | 1.03±0.27a | 1.17±0.35a | 1.27±0.50a | 1.42±0.39a |
Hepatic GSH (µmol/g liver) | 1.78±0.27 | 0.65±0.30a | 0.89±0.35a | 1.08±0.46a | 1.14±0.41a,b |
Hepatic GSSG (µmol/g liver) | 0.07±0.01 | 0.19±0.04a | 0.15±0.07a | 0.14±0.04a | 0.14±0.05a |
Hepatic GSH/GSSG | 27.45±5.61 | 3.74±1.97a | 7.09±4.20a | 8.69±4.56a | 10.87±8.62a,b |
Data expressed as mean ± SD.
Significantly different from control rats by ANOVA (P<0.05)
Significantly different from untreated NAFL rats by ANOVA (P<0.05). ANOVA, one-way analysis of variance; NAFL, non-alcoholic fatty liver; GSH, reduced glutathione; tGSH, total glutathione; GSSG, glutathione disulphide.